Analytic Investors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-119,372
Closed -$953K 645
2016
Q2
$953K Sell
119,372
-158,021
-57% -$1.23M 0.01% 383
2016
Q1
$2.42M Buy
277,393
+107,807
+64% +$896K 0.03% 285
2015
Q4
$1.59M Sell
169,586
-127,516
-43% -$1.1M 0.02% 324
2015
Q3
$2.87M Buy
297,102
+15,147
+5% +$160K 0.04% 248
2015
Q2
$3.27M Buy
281,955
+85,809
+44% +$883K 0.05% 217
2015
Q1
$2.04M Buy
196,146
+62,387
+47% +$584K 0.03% 265
2014
Q4
$1.54M Buy
+133,759
New +$1.32M 0.02% 284
2014
Q2
Sell
-17,061
Closed -$105K 565
2014
Q1
$105K Sell
17,061
-8,650
-34% -$63.6K ﹤0.01% 546
2013
Q4
$225K Sell
25,711
-6,716
-21% -$41.1K ﹤0.01% 465
2013
Q3
$135K Buy
+32,427
New +$179K ﹤0.01% 494

Other funds holding MDXG

Analytic Investors's MDXG Position: Q3 2016 in Review

Analytic Investors sold out of MiMedx Group (MDXG) in Q3 2016, closing a stake of 119,372 shares — an estimated $953K sold.

Analytic Investors first reported a position in MDXG in Q3 2013 and held it in 10 quarters. The position peaked at $3.27M in Q2 2015. 180 funds tracked by Wall St. Rank hold MDXG as of Q3 2016.

  • Analytic Investors reported no remaining MiMedx Group position as of Q3 2016 after selling out during the quarter.
  • Analytic Investors sold 119,372 MiMedx Group shares in Q3 2016, an estimated $953K.
  • Analytic Investors first reported a position in MiMedx Group in Q3 2013 and held it in 10 quarters.
  • Analytic Investors's MiMedx Group position peaked at $3.27M in Q2 2015.
  • 180 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.